The project is aimed to study and expand the availability of drugs for children in chronic pain through the development of a gabapentin formulation appropriate for them.

ROLE OF THE FOUNDATION
The Foundation supported the ethical and regulatory activities related to the clinical studies and coordinates the project Ethics Boards.

FUNDED BY: FP7-HEALTH-2013-INNOVATION-1. GA 602962, 2013 - 2017.

DURATION: Jul 2013 - Jun 2017